companydata.dkcompanydata.dk

PHARMADANICA A/S: Financial statements 2014

CVR: 19056007

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -20,623 and a net result of DKK -39,619 compared with DKK -85,665 the year before. Equity in the 2014 report amounted to DKK 989,348. The solvency ratio was 99.2%.

Gross Profit
DKK -20,623
Profit/Loss
DKK -39,619
Equity
DKK 989,348
Total Assets
DKK 997,148

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--21 t.-40 t.989 t.-
2013--3 t.-86 t.-771 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

PHARMADANICA A/S: The 2013 annual report is outJun 5, 2014

PHARMADANICA A/S has published its annual report for 2013. Gross profit came to DKK -2,570, and the net result was DKK -85,665.

PHARMADANICA A/S appoints new auditorMay 27, 2014

As of May 27, 2014, KPMG P/S has been appointed auditor of PHARMADANICA A/S.

Auditor steps down at PHARMADANICA A/SMay 27, 2014

As of May 27, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of PHARMADANICA A/S.

About PHARMADANICA A/S

PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.

Source: annual report 2026, Danish Business Authority